Topix Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, recently announced that they have partnered with New Mountain Capital LLC, a growth-oriented investment firm that currently manages over $15 bi

Written by  

Topix Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, recently announced that they have partnered with New Mountain Capital LLC, a growth-oriented investment firm that currently manages over $15 billion in assets. Headquartered in Amityville, New York, Topix has developed, manufactured, and marketed highly-innovative and clinically-validated topical skin care products for over 30 years.

Recognized by physicians for the high quality of its products, Topix is uniquely positioned due to its best-in-class formulation capabilities and proprietary product portfolio developed to meet the in-office dispensing needs of physicians and their patients. Topix's product portfolio addresses a wide array of skin health conditions and customized, private label solutions for the professionally dispensed market. Topix utilizes their own state-of-the-art, GMP-compliant facilities to research, develop, manufacture, and test their products to the highest quality standards.

Want to read more?

Subscribe to one of our monthly plans to continue reading this article.

Login to post comments
body { overflow-y: auto; } html, body { min-width: unset; }